Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Parker Institute for Cancer Immunotherapy salaries
Parker Institute for Cancer Immunotherapy salary estimate
$52,178yearly
Parker Institute for Cancer Immunotherapy Salaries Overview
The Parker Institute for Cancer Immunotherapy values its employees and offers an average salary of $52,178 per year. Compensation can vary significantly depending on the role and department. For instance, research positions typically offer higher salaries compared to administrative roles.
Employees can expect competitive pay rates that reflect their expertise and contributions to groundbreaking cancer research. Specific departments, such as clinical research and project management, often see salaries that align with their specialized skill sets. Additionally, the institute provides opportunities for advancement and professional growth, making it an attractive workplace for individuals passionate about cancer immunotherapy.
To explore current job openings and specific salary details by department, visit their careers page where you can find valuable insights tailored to your expertise.
Rate the fairness of Parker Institute for Cancer Immunotherapy's compensation policies.
Do you work at Parker Institute for Cancer Immunotherapy?
Were you satisfied with Parker Institute for Cancer Immunotherapy's salary and benefits?
Parker Institute for Cancer Immunotherapy salaries by department
Salaries at Parker Institute for Cancer Immunotherapy vary depending on the department you work in. Parker Institute for Cancer Immunotherapy salaries in the engineering department are the highest with an average salary of $89,225. Employees in the finance department at Parker Institute for Cancer Immunotherapy receive relatively high salaries as well, with an average salary of $84,408 per year. Departments that don't pay as well at Parker Institute for Cancer Immunotherapy include the facilities and the customer service organizational functions, with employees earning average salaries of $32,385 and $35,041, respectively.
Average Parker Institute for Cancer Immunotherapy salary by department
| Rank | Department | Average Parker Institute for Cancer Immunotherapy salary | Hourly rate |
|---|---|---|---|
| 1 | Engineering | $89,225 | $42.90 |
| 2 | Finance | $84,408 | $40.58 |
| 3 | IT | $78,957 | $37.96 |
| 4 | Plant/Manufacturing | $51,612 | $24.81 |
| 5 | Administrative | $38,504 | $18.51 |
| 6 | Customer Service | $35,042 | $16.85 |
| 7 | Facilities | $32,385 | $15.57 |
Frequently asked questions about Parker Institute for Cancer Immunotherapy salaries
Search for jobs
Zippia gives an in-depth look into the details of Parker Institute for Cancer Immunotherapy, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Parker Institute for Cancer Immunotherapy. The employee data is based on information from people who have self-reported their past or current employments at Parker Institute for Cancer Immunotherapy. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Parker Institute for Cancer Immunotherapy. The data presented on this page does not represent the view of Parker Institute for Cancer Immunotherapy and its employees or that of Zippia.
Parker Institute for Cancer Immunotherapy may also be known as or be related to PARKER INSTITUTE FOR CANCER, Parker Inst For Cancr Immthrpy, Parker Institute For Cancer Immunotherapy and Parker Institute for Cancer Immunotherapy.